Search results for: 'challeng technology'

From traditional incandescent lamps to compact fluorescent lamps (CFL) to light-emitting diodes (LED) and laser diodes (LD), the lighting market has come a long way in the last 10 years. With growing LED adoption and increasing smart solutions, leveraging Internet of Things (IoT) and Light Fidelity (LiFi), the lighting market is going through a pha...

Traditional BPM and customer experience (CX) services are undergoing a paradigm shift. The need for effective and efficient front- and back-office operations has led to process optimization through digitalization. In the past, organizations focused primarily on optimizing their front-office operations (customer facing functions including customer s...

The battery management system (BMS) market is diverse, with multiple applications that use a large number of battery packs. Rising demand for electric vehicles, energy storage systems, and aerospace and defense equipment powered by batteries make BMS an important component in daily life. BMS has evolved from a mere monitoring unit to an advanced, i...

The CX outsourcing services landscape is set to grow throughout the forecast period. Two key reasons lie behind this: 1) the increasing acceptance of CX as a formidable competitive weapon; and 2) growing incentives for companies to outsource their CX operations. Improving CX appears as the number one business goal priority in the Frost & Sulliva...

Healthcare is rapidly becoming patient-centric, focusing on outcomes and value. This offers clinical diagnostics players opportunities to advance their instrument, assay, and informatics capabilities to address unmet clinical needs and increase the precision diagnostics portfolio. Advances in next-generation sequencing-based companion diagnosti...

Both predictive and prognostic biomarkers constitutes an central element in each and every targeted oncology drug discovery and development program. Breakthrough technologies allowing leveraging biomarkers for oncology are paving the way of personalized medicine and precision oncology. Indeed, oncology biomarkers provide the clinical community with...

This study explores the transformative potential of organoid technologies in advancing cancer research, precision medicine, and drug discovery. Organoids—3D cell culture systems derived from patient tumors—preserve tumor heterogeneity and provide physiologically relevant models for studying cancer biology, therapeutic response, and resistance mecha...

PACCAR Inc is expected to increase its medium- and heavy-duty truck unit sales at a compound annual growth rate of 4.8% from 2016 to 2025, which will help it maintain its share of the global truck market. While rising unit sales will not be the key driver for sustained profitability, revenue from services such as telematics-based fleet management s...

Artificial intelligence is becoming increasingly relevant to antibody discovery and immunotherapy development, supporting target identification, de novo antibody design, antibody engineering, clinical intelligence, and bioprocessing. Advances in generative AI, protein language models, diffusion models, and structure-based models are expanding the u...